BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 34770940)

  • 1. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
    Friedli MJ; Inestrosa NC
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
    Wang R; Tang XC
    Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalent ligands derived from Huperzine A as acetylcholinesterase inhibitors.
    Haviv H; Wong DM; Silman I; Sussman JL
    Curr Top Med Chem; 2007; 7(4):375-87. PubMed ID: 17305579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.
    Zangara A
    Pharmacol Biochem Behav; 2003 Jun; 75(3):675-86. PubMed ID: 12895686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huperzia quadrifariata and Huperzia reflexa alkaloids inhibit acetylcholinesterase activity in vivo in mice brain.
    Konrath EL; Neves BM; Passos Cdos S; Lunardi PS; Ortega MG; Cabrera JL; Gonçalves CA; Henriques AT
    Phytomedicine; 2012 Nov; 19(14):1321-4. PubMed ID: 23022390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.
    Patocka J
    Acta Medica (Hradec Kralove); 1998; 41(4):155-7. PubMed ID: 9951045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinesterase activity and identification of huperzine A in three Mexican lycopods: Huperzia cuernavacensis, Huperzia dichotoma and Huperzia linifolia (Lycopodiaceae).
    García MV; Poser GLV; Apel M; Tlatilpa RC; Mendoza-Ruiz A; Villarreal ML; Henriques AT; Taketa AC
    Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):235-239. PubMed ID: 28625948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
    Wang R; Yan H; Tang XC
    Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model.
    Wang CY; Zheng W; Wang T; Xie JW; Wang SL; Zhao BL; Teng WP; Wang ZY
    Neuropsychopharmacology; 2011 Apr; 36(5):1073-89. PubMed ID: 21289607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huperzine A from Huperzia species--an ethnopharmacolgical review.
    Ma X; Tan C; Zhu D; Gang DR; Xiao P
    J Ethnopharmacol; 2007 Aug; 113(1):15-34. PubMed ID: 17644292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia.
    Zhang HY; Zheng CY; Yan H; Wang ZF; Tang LL; Gao X; Tang XC
    Chem Biol Interact; 2008 Sep; 175(1-3):396-402. PubMed ID: 18565502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.
    Wang Y; Tang XC; Zhang HY
    J Neurosci Res; 2012 Feb; 90(2):508-17. PubMed ID: 22002568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into huperzine A for the treatment of Alzheimer's disease.
    Zhang HY
    Acta Pharmacol Sin; 2012 Sep; 33(9):1170-5. PubMed ID: 22941287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analogs of huperzine A improve survival in guinea pigs exposed to soman.
    Gunosewoyo H; Tipparaju SK; Pieroni M; Wang Y; Doctor BP; Nambiar MP; Kozikowski AP
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1544-7. PubMed ID: 23395652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on huperzine A as a treatment for Alzheimer's disease.
    Little JT; Walsh S; Aisen PS
    Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
    Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
    J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huperzine A production by Paecilomyces tenuis YS-13, an endophytic fungus isolated from Huperzia serrata.
    Su J; Yang M
    Nat Prod Res; 2015; 29(11):1035-41. PubMed ID: 25427833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselectivities of enantiomers of huperzine A in protection against beta-amyloid(25-35)-induced injury in PC12 and NG108-15 cells and cholinesterase inhibition in mice.
    Zhang HY; Liang YQ; Tang XC; He XC; Bai DL
    Neurosci Lett; 2002 Jan; 317(3):143-6. PubMed ID: 11755260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lycopodium alkaloids.
    Ma X; Gang DR
    Nat Prod Rep; 2004 Dec; 21(6):752-72. PubMed ID: 15565253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.